beyoungd-asia.com

Experts & Summit Forum

Stay curious, stay safe!

Keynote speech

Dr. Grace G

PV head of B. MNC

Mar 2025

Pharmacovigilance is crucial for ensuring the safety of medicines throughout their lifecycle, from initial human trials to withdrawal from the market. Dr. G was invited to give this speech, which was focus on raising PV awareness, illustrating its impact through notable examples, and empowering individuals to contribute to safer medication use.

The presentation stands out for its blend of real-world case studies, concise explanation of PV processes, and emphasis on individual and collective responsibility. Its global scope and reference to key guidelines (EMA, ICH, CIOMS, WHO) position it as a valuable primer for healthcare professionals, students, and anyone interested in medicine safety.

The call to “Stay Curious, Stay Safe!” encapsulates the proactive spirit and ongoing vigilance needed in pharmacovigilance.

Science Forum

2026 JPM Participation Guide Released!

From January 12 to 15, 2026, the J.P. Morgan Healthcare Conference will take place at the Westin St. Francis in San Francisco. This is the most influential stage in the global healthcare investment arena, bringing together over 3,000 CEOs, senior executives, fund managers, and entrepreneurs worldwide.

This conference is far more than a New Year gathering—it is the watershed moment that shapes the trajectory of capital and innovation for the entire year ahead. Over the past two years, JPM Week has facilitated over $100 billion in deals, and in 2026, with the dual waves of AI-driven therapies and RNA-based drugs, it is widely regarded as the starting point of a new cycle.

Experts & Summit Forum

Experts & Summit Forum - “Science forum”

On September 21 in Shanghai, the 2025 Pujiang Innovation Forum’s AI Empowering Scientific Research sub-forum highlighted the establishment of a strategic alliance to drive integrated scientific innovation through AI. A notable focus was placed on the use of AI in biomanufacturing and brain science, aiming to accelerate breakthrough discoveries and technological advancements in these biological fields.

The alliance intends to strengthen cross-disciplinary collaboration—particularly between AI and biological sciences—by promoting integration in theoretical research, technology development, and practical application. Discussions emphasized how AI-powered intelligent agents facilitate automation, interdisciplinary cooperation, and rapid evolution in biomanufacturing, brain science, and related domains.

Key achievements released at the forum demonstrated China’s significant progress in integrating AI with biology, including new approaches to biomedical research, enhanced innovation capacity, and deeper cooperation among leading institutions. Strategic agreements signed at the event further reinforce talent development and joint R&D targeting biological and life sciences.

Bio Pacific Conference

Experts & Summit Forum - “Science forum”

The 2025 BioPacific Conference, hosted by CABS on September 13 in South San Francisco, centered on “Frontiers in Healthcare: Forging Global Impact Through Science, Innovation, and Partnership.”

The conference agenda emphasized major advances and future trends in life sciences, drug development, neuroscience, gene regulation, cell pharmacology, antibody-drug conjugates (ADC), and AI application in medicine. Keynote speakers presented breakthroughs in RNA therapies, precision medicine, neurodegenerative disease modeling, and AI-driven medical imaging.

Three high-impact summit forums promoted interactive discussions on artificial intelligence in drug discovery, cross-border healthcare collaboration, and biotech enterprise growth paths. Experts highlighted the transformative role of generative AI, molecular modeling, and virtual screening, focusing on successful practices and unresolved challenges in the field. The conference showcased the dynamic progress and global potential of the biopharmaceutical sector through high-level exchange and multidisciplinary innovation.